Your browser doesn't support javascript.
loading
A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study.
Mead, Adam J; Butt, Nauman M; Nagi, Waseem; Whiteway, Alastair; Kirkpatrick, Suriya; Rinaldi, Ciro; Roughley, Catherine; Ackroyd, Sam; Ewing, Joanne; Neelakantan, Pratap; Garg, Mamta; Tucker, David; Murphy, John; Patel, Hitesh; Bains, Rozinder; Chiu, Gavin; Hickey, Joe; Harrison, Claire; Somervaille, Tim C P.
Afiliación
  • Mead AJ; NIHR Oxford Biomedical Research Centre and MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Headington, Oxford OX3 9DS, UK.
  • Butt NM; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
  • Nagi W; Mid Essex Hospital Services NHS Trust, Chelmsford, UK.
  • Whiteway A; North Bristol NHS Trust, Bristol, UK.
  • Kirkpatrick S; North Bristol NHS Trust, Bristol, UK.
  • Rinaldi C; United Lincolnshire Hospitals NHS Trust, Boston, UK.
  • Roughley C; East Kent Hospitals University NHS Foundation Trust, Canterbury, UK.
  • Ackroyd S; Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • Ewing J; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Neelakantan P; Royal Berkshire NHS Foundation Trust, Reading, UK.
  • Garg M; University Hospitals Leicester NHS Trust, Leicester, UK.
  • Tucker D; Royal Cornwall Hospital NHS Trust, Truro, UK.
  • Murphy J; University Hospital Monklands, NHS Lanarkshire, Airdrie, UK.
  • Patel H; Royal Albert Edward Infirmary, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK.
  • Bains R; Novartis Pharmaceuticals UK Limited, Camberley, UK.
  • Chiu G; Novartis Pharmaceuticals UK Limited, Camberley, UK.
  • Hickey J; OPEN Health, Marlow, UK.
  • Harrison C; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Somervaille TCP; Cancer Research UK Manchester Institute, Manchester, UK.
Ther Adv Hematol ; 13: 20406207221084487, 2022.
Article en En | MEDLINE | ID: mdl-35371428

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Ther Adv Hematol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Ther Adv Hematol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido